{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:26:24Z","timestamp":1791779184247,"version":"4.3.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["heartandlung.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.hrtlng.2024.04.019","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T17:37:05Z","timestamp":1715794625000},"page":"121-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of the safety and efficacy of direct oral anticoagulants compared with vitamin-k antagonists in the treatment of left ventricular thrombosis. A systematic review and meta-analysis"],"prefix":"10.1016","volume":"67","author":[{"given":"Maryam","family":"Mehrpooya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Rafi","family":"Barakzehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Nikoobakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.hrtlng.2024.04.019_bib0001","doi-asserted-by":"crossref","first-page":"e706","DOI":"10.1097\/MJT.0000000000000722","article-title":"Rivaroxaban used for treatment of a left ventricular thrombus in a patient with nonischemic cardiomyopathy","volume":"25","author":"Abubakar","year":"2018","journal-title":"Am J Ther"},{"issue":"7","key":"10.1016\/j.hrtlng.2024.04.019_bib0002","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamacardio.2018.1086","article-title":"Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment","volume":"3","author":"McCarthy","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.hrtlng.2024.04.019_bib0003","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/clc.23039","article-title":"Left ventricular thrombosis in acute anterior myocardial infarction: evaluation of hospital mortality, thromboembolism, and bleeding","volume":"41","author":"Ram","year":"2018","journal-title":"Clin Cardiol"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.04.019_bib0004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.04.019_bib0005","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.amjcard.2019.10.033","article-title":"Safety and efficacy of direct oral anticoagulants versus warfarin in patients with chronic kidney disease and atrial fibrillation","volume":"125","author":"Makani","year":"2020","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.hrtlng.2024.04.019_bib0006","first-page":"1968","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood, J Am Soc Hematol"},{"issue":"15","key":"10.1016\/j.hrtlng.2024.04.019_bib0007","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"Buller","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hrtlng.2024.04.019_bib0008","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/STROKEAHA.121.037541","article-title":"Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study","volume":"53","author":"Yaghi","year":"2022","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.hrtlng.2024.04.019_bib0009","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"EP Europace"},{"issue":"9","key":"10.1016\/j.hrtlng.2024.04.019_bib0010","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.7326\/M20-7141","article-title":"Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation: a cohort study","volume":"174","author":"Kim","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0011","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2147\/TCRM.S84210","article-title":"New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events","volume":"11","author":"Mekaj","year":"2015","journal-title":"Ther Clin Risk Manag"},{"issue":"12","key":"10.1016\/j.hrtlng.2024.04.019_bib0012","first-page":"1333","article-title":"Direct oral anticoagulants: new drugs and new concepts","volume":"7","author":"Levy","year":"2014","journal-title":"JACC: Cardiovas Interv,"},{"issue":"16","key":"10.1016\/j.hrtlng.2024.04.019_bib0013","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.04.019_bib0014","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/europace\/euu311","article-title":"Non-vitamin K antagonist oral anticoagulants: considerations on once-vs. twice-daily regimens and their potential impact on medication adherence","volume":"17","author":"Vrijens","year":"2015","journal-title":"EP Europace"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0015","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0016","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00380-014-0562-z","article-title":"Successful resolution of a left ventricular thrombus with apixaban treatment following acute myocardial infarction","volume":"31","author":"Mano","year":"2016","journal-title":"Heart Vessels"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0017","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00380-013-0403-5","article-title":"Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran","volume":"29","author":"Nagamoto","year":"2014","journal-title":"Heart Vessels"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0018","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0019","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.hrtlng.2024.04.019_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"23","key":"10.1016\/j.hrtlng.2024.04.019_bib0021","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hrtlng.2024.04.019_bib0022","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","author":"Investigators","year":"1993","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.hrtlng.2024.04.019_bib0023","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.04.019_bib0024","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"7414","key":"10.1016\/j.hrtlng.2024.04.019_bib0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.04.019_bib0026","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.hrtlng.2024.04.019_bib0027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"7109","key":"10.1016\/j.hrtlng.2024.04.019_bib0028","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.hrtlng.2024.04.019_bib0029","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s43044-021-00164-7","article-title":"Rivaroxaban versus warfarin for the management of left ventricle thrombus","volume":"73","author":"Albabtain","year":"2021","journal-title":"Egyptian Heart J"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12959-020-00242-x","article-title":"Direct oral anticoagulant use in left ventricular thrombus","volume":"18","author":"Ali","year":"2020","journal-title":"Thromb J"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.04.019_bib0031","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11239-020-02371-6","article-title":"Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus","volume":"52","author":"Bass","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.04.019_bib0032","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/1074248420967644","article-title":"Direct oral anticoagulants in the treatment of left ventricular thrombus: a retrospective, multicenter study and meta-analysis of existing data","volume":"26","author":"Cochran","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.04.019_bib0033","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40261-020-00898-3","article-title":"Management of left ventricular thrombi with direct oral anticoagulants: retrospective comparative study with vitamin K antagonists","volume":"40","author":"Daher","year":"2020","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0034","first-page":"w02052","article-title":"Direct oral anticoagulants versus vitamin K-antagonists for treatment of left ventricular thrombus\u2014Insights from multicenter registry","volume":"22","author":"Durrer-Ariyakuddy","year":"2019","journal-title":"Cardiovas Med"},{"issue":"supplement_1","key":"10.1016\/j.hrtlng.2024.04.019_bib0035","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz747.0118","article-title":"Direct oral anticoagulants are an effective therapy for left ventricular thrombus formation","volume":"40","author":"Gama","year":"2019","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.hrtlng.2024.04.019_bib0036","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.amjmed.2020.05.025","article-title":"Treatment of left ventricular thrombus with direct oral anticoagulants: a retrospective observational study","volume":"133","author":"Guddeti","year":"2020","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.04.019_bib0037","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40256-022-00533-w","article-title":"Safety and effectiveness of direct oral anticoagulants versus warfarin for treating left ventricular thrombus","volume":"22","author":"Herald","year":"2022","journal-title":"Am J Cardiovas Drugs"},{"issue":"5","key":"10.1016\/j.hrtlng.2024.04.019_bib0038","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/ehf2.12718","article-title":"Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus","volume":"7","author":"Iqbal","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10.1016\/j.hrtlng.2024.04.019_bib0039","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/FJC.0000000000000987","article-title":"Evaluation of direct oral anticoagulants versus warfarin for intracardiac thromboses","volume":"77","author":"Iskaros","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"10.1016\/j.hrtlng.2024.04.019_bib0040","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.cjca.2018.07.194","article-title":"Treatment of left ventricular thrombus using warfarin versus direct oral anticoagulants following anterior myocardial infarction","volume":"34","author":"Jaidka","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0041","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2019.11.056","article-title":"Left ventricular thrombus: patient characteristics and treatment from a single tertiary centre's experience","volume":"297","author":"Lim","year":"2019","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.hrtlng.2024.04.019_bib0042","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s11739-021-02788-8","article-title":"Direct oral anticoagulants versus warfarin for the treatment of left ventricular thrombosis","volume":"16","author":"Mihm","year":"2021","journal-title":"Intern Emerg Med"},{"issue":"Suppl_3","key":"10.1016\/j.hrtlng.2024.04.019_bib0043","doi-asserted-by":"crossref","first-page":"A16816","DOI":"10.1161\/circ.142.suppl_3.16816","article-title":"Direct oral anticoagulants compared to warfarin for the treatment of left ventricular thrombus: a multi-center experience","volume":"142","author":"Minciunescu","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hrtlng.2024.04.019_bib0044","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2022-002111","article-title":"Improving the management of left ventricular thrombus in a tertiary cardiology centre: a quality improvement project","volume":"12","author":"Rahunathan","year":"2023","journal-title":"BMJ Open Qual"},{"issue":"1526","key":"10.1016\/j.hrtlng.2024.04.019_bib0045","first-page":"45","article-title":"Left ventricular thrombus after ST segment elevation myocardial infarction: a single-centre observational study","volume":"133","author":"Ratnayake","year":"2020","journal-title":"N Z Med J (Online)"},{"issue":"6","key":"10.1016\/j.hrtlng.2024.04.019_bib0046","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2020.0652","article-title":"Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi","volume":"5","author":"Robinson","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0047","doi-asserted-by":"crossref","first-page":"212","DOI":"10.11604\/pamj.2021.39.212.28585","article-title":"Treatment and outcomes in patients with left ventricular thrombus - experiences from the Aga Khan University Hospital, Nairobi - Kenya","volume":"39","author":"Varwani","year":"2021","journal-title":"Pan Afr Med J"},{"issue":"7","key":"10.1016\/j.hrtlng.2024.04.019_bib0048","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/1060028020975111","article-title":"Direct oral anticoagulants versus warfarin in the treatment of left ventricular thrombus","volume":"55","author":"Willeford","year":"2021","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.hrtlng.2024.04.019_bib0049","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.21037\/apm-21-1683","article-title":"Direct oral anticoagulants versus vitamin K antagonists for patients with left ventricular thrombus","volume":"10","author":"Xu","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"11S","key":"10.1016\/j.hrtlng.2024.04.019_bib0050","doi-asserted-by":"crossref","first-page":"A981","DOI":"10.1016\/S0735-1097(18)31522-5","article-title":"Direct oral anticoagulants compared to warfarin for left ventricular thrombi: a single center experience","volume":"71","author":"Robinson","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0051","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.amjcard.2023.01.018","article-title":"Direct oral anticoagulants versus vitamin K antagonists for the treatment of left ventricular thrombi-insights from a Swiss multicenter registry","volume":"194","author":"Seiler","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/7400860","article-title":"Different oral antithrombotic therapy for the treatment of ventricular thrombus: an observational study from 2010 to 2019","volume":"2022","author":"Yang","year":"2022","journal-title":"Int J Clin Pract"},{"issue":"11_Supplement_1","key":"10.1016\/j.hrtlng.2024.04.019_bib0053","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0735-1097(20)31575-8","article-title":"Direct oral anticoagulants are effective therapy in treating left ventricular thrombi","volume":"75","author":"Yunis","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hrtlng.2024.04.019_bib0054","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00380-021-01921-z","article-title":"Rivaroxaban versus vitamin K antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction","volume":"37","author":"Zhang","year":"2022","journal-title":"Heart Vessels"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0055","doi-asserted-by":"crossref","first-page":"ehz746","DOI":"10.1093\/eurheartj\/ehz746.1020","article-title":"P6426 The use of direct oral anti-coagulations (DOACs) compared to vitamin K antagonist in patients with left ventricular thrombus after acute myocardial infarction","volume":"40","author":"Alizadeh","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.hrtlng.2024.04.019_bib0056","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/ehjcvp\/pvaa096","article-title":"The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction","volume":"7","author":"Jones","year":"2021","journal-title":"Eur Heart J - Cardiovas Pharmacother"},{"issue":"12","key":"10.1016\/j.hrtlng.2024.04.019_bib0057","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jacc.2021.01.049","article-title":"Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT Trial)","volume":"77","author":"Abdelnabi","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hrtlng.2024.04.019_bib0058","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ehjcvp\/pvab057","article-title":"Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial\u2021","volume":"8","author":"Alcalai","year":"2022","journal-title":"Eur Heart J - Cardiovas Pharmacother"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.04.019_bib0059","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/JCPC.JCPC_41_20","article-title":"Apixaban versus warfarin in patients with left ventricular thrombus: a pilot prospective randomized outcome blinded study investigating size reduction or resolution of left ventricular thrombus","volume":"9","author":"Isa","year":"2020","journal-title":"J Clin Prev Cardiol"},{"issue":"3","key":"10.1016\/j.hrtlng.2024.04.019_bib0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cjco.2022.12.003","article-title":"Apixaban in patients with post-myocardial infarction left ventricular thrombus: a randomized clinical trial","volume":"5","author":"Youssef","year":"2023","journal-title":"CJC Open"},{"issue":"9","key":"10.1016\/j.hrtlng.2024.04.019_bib0061","doi-asserted-by":"crossref","first-page":"312","DOI":"10.31083\/j.rcm2309312","article-title":"Direct oral anticoagulants versus vitamin K antagonists for the treatment of left ventricular thrombosis: a meta-analysis","volume":"23","author":"Li","year":"2022","journal-title":"Rev Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.hrtlng.2024.04.019_bib0062","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1002\/ehf2.14084","article-title":"Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus","volume":"9","author":"Huang","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.hrtlng.2024.04.019_bib0063","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.repc.2021.11.013","article-title":"Effect of direct oral anticoagulants versus vitamin K antagonists or warfarin in patients with left ventricular thrombus outcomes: a systematic review and meta-analysis","volume":"42","author":"da Silva Ferreira","year":"2023","journal-title":"Rev Port Cardiol"},{"issue":"6","key":"10.1016\/j.hrtlng.2024.04.019_bib0064","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/FJC.0000000000001270","article-title":"Direct oral anticoagulants versus vitamin K antagonists for the treatment of left ventricular thrombus: an updated meta-analysis of cohort studies and randomized controlled trials","volume":"79","author":"Chen","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.04.019_bib0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.18087\/cardio.2023.2.n2200","article-title":"Efficacy and safety of direct oral anticoagulants versus vitamin K antagonists for left ventricular thrombus: an updated systematic review and meta-analysis","volume":"63","author":"Golukhova","year":"2023","journal-title":"Kardiologiia"},{"issue":"9","key":"10.1016\/j.hrtlng.2024.04.019_bib0066","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.cjco.2021.04.007","article-title":"Direct oral anticoagulants vs. vitamin K antagonists in left ventricular thrombi: a systematic review and meta-analysis","volume":"3","author":"Michael","year":"2021","journal-title":"CJC open"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.04.019_bib0067","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MCA.0000000000001230","article-title":"An evidence-based evaluation of left ventricular thrombus treatment, outcomes, and resolution: a systematic review, pooled analysis and meta-analysis","volume":"34","author":"Kwok","year":"2023","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0068","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00228-013-1510-z","article-title":"Novel oral anticoagulants: clinical pharmacology, indications and practical considerations","volume":"69","author":"Harder","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.hrtlng.2024.04.019_bib0069","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/ehf2.14369","article-title":"Factors influencing left ventricular thrombus resolution and its significance on clinical outcomes","volume":"10","author":"Kim","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0070","article-title":"Resolution of left ventricular postinfarction thrombi in patients undergoing percutaneous coronary intervention using rivaroxaban in addition to dual antiplatelet therapy","volume":"2016","author":"Makrides","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.04.019_bib0071","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0735-1097(90)90275-T","article-title":"Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction","volume":"15","author":"Keren","year":"1990","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hrtlng.2024.04.019_bib0072","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.05.017","article-title":"International normalized ratio variability: a measure of anticoagulation quality or a powerful mortality predictor","volume":"24","author":"Vanerio","year":"2015","journal-title":"J Stroke Cerebrovas Dis"},{"issue":"3","key":"10.1016\/j.hrtlng.2024.04.019_bib0073","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/eurheartj\/ehx551","article-title":"Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction","volume":"39","author":"Maniwa","year":"2018","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.hrtlng.2024.04.019_bib0074","doi-asserted-by":"crossref","first-page":"648","DOI":"10.12968\/hmed.2018.79.11.648","article-title":"Warfarin-resistant left ventricular thrombus completely dissolved by rivaroxaban","volume":"79","author":"Huang","year":"2018","journal-title":"Br J Hosp Med"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.04.019_bib0075","doi-asserted-by":"crossref","first-page":"e14065","DOI":"10.1097\/MD.0000000000014065","article-title":"Resolution of left ventricular thrombus by edoxaban after failed treatment with warfarin overdose: a case report","volume":"98","author":"Kao","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0076","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jfma.2023.10.007","article-title":"Direct oral anticoagulants compared with other strategies in patients with atrial fibrillation and stroke or transient ischemic attack: systematic review","volume":"123","author":"Lee","year":"2023","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"10.1016\/j.hrtlng.2024.04.019_bib0077","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jcph.2267","article-title":"Direct oral anticoagulation versus warfarin in left ventricular thrombus: pooled analysis of randomized controlled trials","volume":"63","author":"Sahl\u00e9n","year":"2023","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.hrtlng.2024.04.019_bib0078","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1099591","article-title":"Safety and efficacy of direct oral anticoagulants in bioprosthetic valves: a systematic review and meta-analysis","volume":"10","author":"Bakr","year":"2023","journal-title":"Front Cardiovas Med"},{"issue":"5","key":"10.1016\/j.hrtlng.2024.04.019_bib0079","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ihj.2015.06.010","article-title":"Dabigatran for left ventricular thrombus","volume":"67","author":"Kolekar","year":"2015","journal-title":"Indian Heart J"},{"issue":"3","key":"10.1016\/j.hrtlng.2024.04.019_bib0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2217\/fca.14.12","article-title":"Resolution of left ventricular thrombus by rivaroxaban","volume":"10","author":"Padilla P\u00e9rez","year":"2014","journal-title":"Future Cardiol"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956324000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956324000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T03:35:25Z","timestamp":1719632125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956324000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":80,"alternative-id":["S0147956324000839"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2024.04.019","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the safety and efficacy of direct oral anticoagulants compared with vitamin-k antagonists in the treatment of left ventricular thrombosis. A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2024.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}